NMP22 antibody, as a specific recognition substance of the biosensor, was immobilized on the surface of gold film using a chemical crosslinking method to prepare optical fiber sensing probes. Under ...

Investigators compared diagnostic accuracy of this approach with that of the NMP22 test and a urine cytology test. The analysis included 1,099 patients (55.9% men) aged older than 39 years ...

However, its specificity for ruling out high-grade or invasive disease (87.8% vs 91.6% and 99.5%) and overall bladder cancer (88.8% vs 91.9% and 99.5%) were lower compared with the NMP22 test or ...

Bladder cancer diagnosis typically relies on invasive procedures like cystoscopy, which can be uncomfortable and costly for patients. Urinary biomarkers have been explored as a non-invasive ...

However, its specificity for ruling out high-grade or invasive disease (87.8% vs 91.6% and 99.5%) and overall bladder cancer (88.8% vs 91.9% and 99.5%) were lower compared with the NMP22 test or ...

A urinary DNA methylation test demonstrated high sensitivity and specificity for detecting high-grade or invasive bladder cancer, outperforming both nuclear matrix protein 22 (NMP22) and urine ...

Abstract. Introduction: Bladder cancer (BlCa) ranks as the sixth most prevalent cancer in the world. A number of urine based BlCa detection tests have recently been approved for clinical use, ...

BTA stat®, NMP22® BladderChek®, UBC® Rapid Test, and CancerCheck® UBC® rapid VISUAL are urinary-based rapid tests. This multicenter study is the first study comparing all available rapid tests on a ...

Squamous cell carcinoma (SCC) of the bladder is common in many regions around the world. Prognosis is very poor, as most cases are diagnosed at an advanced stage due to a lack of affordable and valid ...